MD Anderson Cancer Center signs deal with Elekta

The University of Texas MD Anderson Cancer Center announced this week it has signed a deal with Elekta, a radiation therapy technology company based out of Stockholm, Sweden, to acquire several products and services.

The deal includes Elekta Infinity linear accelerators, high-dose-rate brachytherapy afterloaders, software, and maintenance services.

“As a world-renowned cancer center, MD Anderson has been a technology leader in managing the disease,” Bill Yaeger, Elekta executive vice president, North America region, said in a prepared statement.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.